75 related articles for article (PubMed ID: 1610488)
21. Platelet membrane properties in Alzheimer and multi-infarct dementias.
Hicks N; Brammer MJ; Hymas N; Levy R
Alzheimer Dis Assoc Disord; 1987; 1(2):90-7. PubMed ID: 3453744
[TBL] [Abstract][Full Text] [Related]
22. Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vivo effect of zinc on platelet membranes and cognition.
Potocnik FC; van Rensburg SJ; Park C; Taljaard JJ; Emsley RA
S Afr Med J; 1997 Sep; 87(9):1116-9. PubMed ID: 9358828
[TBL] [Abstract][Full Text] [Related]
23. Markedly increased platelet membrane fluidity in Down syndrome with a (14q, 21q) translocation.
Zubenko GS; Howland R
J Geriatr Psychiatry Neurol; 1988; 1(4):218-9. PubMed ID: 2978118
[TBL] [Abstract][Full Text] [Related]
24. Lipid peroxidation and platelet membrane fluidity--implications for Alzheimer's disease?
van Rensburg SJ; Daniels WM; van Zyl J; Potocnik FC; van der Walt BJ; Taljaard JJ
Neuroreport; 1994 Nov; 5(17):2221-4. PubMed ID: 7881031
[TBL] [Abstract][Full Text] [Related]
25. SOD-1 activity and platelet membrane fluidity in Alzheimer's disease.
Zubenko GS; Sauer P
Biol Psychiatry; 1989 Mar; 25(6):671-8. PubMed ID: 2923930
[TBL] [Abstract][Full Text] [Related]
26. Neuropathologic correlates of late-onset major depression.
Sweet RA; Hamilton RL; Butters MA; Mulsant BH; Pollock BG; Lewis DA; Lopez OL; DeKosky ST; Reynolds CF
Neuropsychopharmacology; 2004 Dec; 29(12):2242-50. PubMed ID: 15354182
[TBL] [Abstract][Full Text] [Related]
27. Endoplasmic reticulum abnormality in Alzheimer's disease: selective alteration in platelet NADH-cytochrome c reductase activity.
Zubenko GS
J Geriatr Psychiatry Neurol; 1989; 2(1):3-10. PubMed ID: 2742732
[TBL] [Abstract][Full Text] [Related]
28. Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease.
Järemo P; Milovanovic M; Buller C; Nilsson S; Winblad B
Platelets; 2012; 23(2):116-20. PubMed ID: 22150375
[TBL] [Abstract][Full Text] [Related]
29. Differences in coated-platelet production between frontotemporal dementia and Alzheimer disease.
Prodan CI; Ross ED; Vincent AS; Dale GL
Alzheimer Dis Assoc Disord; 2009; 23(3):234-7. PubMed ID: 19812465
[TBL] [Abstract][Full Text] [Related]
30. [Trends in the studies of blood platelet membranes].
Watanabe K; Ando Y
Nihon Rinsho; 1978 Dec; 36(12):3776-88. PubMed ID: 372616
[No Abstract] [Full Text] [Related]
31. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
32. P-selectin paradox and dementia of the Alzheimer type: circulating P-selectin is increased but platelet-bound P-selectin after agonist provocation is compromised.
Järemo P; Milovanovic M; Buller C; Nilsson S; Winblad B
Scand J Clin Lab Invest; 2013 Mar; 73(2):170-4. PubMed ID: 23421771
[TBL] [Abstract][Full Text] [Related]
33. Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia.
Tukiainen E; Wikström J; Kilpeläinen H
Med Biol; 1981 Apr; 59(2):116-20. PubMed ID: 6458746
[TBL] [Abstract][Full Text] [Related]
34. Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study.
Sundelöf J; Kilander L; Helmersson J; Larsson A; Rönnemaa E; Degerman-Gunnarsson M; Sjögren P; Basun H; Lannfelt L; Basu S
J Alzheimers Dis; 2009; 18(1):71-8. PubMed ID: 19542632
[TBL] [Abstract][Full Text] [Related]
35. Platelet membrane fluidity in non-insulin-dependent diabetes mellitus (NIDDM) subjects, in subjects with vascular atherosclerotic disease (VAD) and in VAD subjects with NIDDM.
Caimi G; Canino B; Montana M; Catania A; Lo Presti R
Thromb Haemost; 1999 Jul; 82(1):149. PubMed ID: 10456470
[No Abstract] [Full Text] [Related]
36. Platelet membrane fluidity.
Pettegrew JW
Neurology; 1993 Jan; 43(1):234; author reply 235-6. PubMed ID: 8423902
[No Abstract] [Full Text] [Related]
37. Inheritance pattern of platelet membrane fluidity in Alzheimer disease.
Chakravarti A; Slaugenhaupt SA; Zubenko GS
Am J Hum Genet; 1989 Jun; 44(6):799-805. PubMed ID: 2729275
[TBL] [Abstract][Full Text] [Related]
38. Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controls.
Kukull WA; Hinds TR; Schellenberg GD; van Belle G; Larson EB
Neurology; 1992 Mar; 42(3 Pt 1):607-14. PubMed ID: 1549223
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.
Hansson O; Stomrud E; Vanmechelen E; Östling S; Gustafson DR; Zetterberg H; Blennow K; Skoog I
J Alzheimers Dis; 2012; 28(1):231-8. PubMed ID: 21955816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
